STAGE IIIA PROSTATE CANCER AJCC V8
Clinical trials for STAGE IIIA PROSTATE CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIA PROSTATE CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIIA PROSTATE CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets Hard-to-Treat cancers with gene mutations
Disease control CompletedThis early-phase study tested a new drug (AZD8186) combined with chemotherapy (docetaxel) in 23 adults with advanced solid tumors that have certain gene changes (PTEN or PIK3CB mutations). The main goal was to find the safest dose and understand side effects. Researchers hope thi…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:25 UTC
-
Shorter radiation blasts prostate cancer after surgery – fewer trips, same hope
Disease control CompletedThis study tested a shorter course of radiation (hypofractionation) in 52 men with prostate cancer who had high-risk features after their prostate was removed. The goal was to see if giving higher daily doses over fewer days could better prevent the cancer from coming back. The a…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 29, 2026 15:03 UTC
-
Cancer moonshot study banks tumors to unlock genetic secrets
Knowledge-focused CompletedThis study collected blood and tumor tissue from 64 people with advanced or treatment-resistant cancers. Researchers stored these samples to study how genes affect cancer growth and response to therapy. No new treatment was given; the goal was to build a resource for future resea…
Matched conditions: STAGE IIIA PROSTATE CANCER AJCC V8
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 29, 2026 15:02 UTC